Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 1, 1997, Pages 61-66

  Kong, Ling Yuan ^a   McMillian, Michael K ^a   Hudson, Pearlie M ^a   Jin, Lei ^a   Hong, Jau Shyong ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; CYTOKINE; DYNORPHIN; DYNORPHIN A; DYNORPHIN A DERIVATIVE; DYNORPHIN[1-8]; DYNORPHIN[2-17][1 TYROSINE]; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; NALOXONE; NITRIC OXIDE; NORBINALTORPHIMINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLIA CELL; MOUSE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; CELLS, CULTURED; DYNORPHINS; LIPOPOLYSACCHARIDES; MICE; NALTREXONE; NEUROGLIA; NITRIC OXIDE; PEPTIDE FRAGMENTS; PYRROLIDINES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030968077     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. ADER, R., FELTEN, D. AND COHEN, N.: Interactions between the brain and immune system. Annu. Rev. Pharmacol. Toxicol. 30: 561-602, 1990.
2. APTE, R. N., DURUM, S. K. AND OPPENHEIM, J. J.: Opioids modulate interleukin-1 production and secretion by bone-marrow macrophages. Immunol. Lett. 24: 141- 148, 1990.
3. BLALOCK, J. E.: A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol. Rev. 69: 1-32, 1989.
4. BRONSTEIN, D. M., PEREZ-OTANO, I., SUN, V., MULLIS SAWIN, S. B., CHAN, J., WU, G.-C., HUDSON, P. M., KONG, L.-Y., HONG, J.-S. AND McMILLIAN, M. K.: Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res. 704: 112-116, 1995.
5. BROWN, S. L. AND VAN EPPS, D. E.: Suppression of T-lymphocyte chemotactic factor production by the opioid peptides beta-endorphin and Metenkephalin. J. Immunol. 134: 3384-3388, 1985.
6. CARR, D. J. J.: The role of endogenous opioids and their receptors in the immune system. Proc. Soc. Exp. Biol. Med. 198: 710-720, 1991.
7. CARR, D. J. J. AND BLALOCK, J. E.: Neuropeptide hormones and receptors common to the immune and neuroendocrine systems: Bidirectional pathway of inter-system communication. In Psychoneuroimmunology, ed. by R. Ader, N. Cohen and D. L. Felten, pp. 573-588, Academic Press, New York, 1991.
8. CHAO, C. C., Hu, S., CLOSE, K., CHOI, C. S., MOLITOR, T. W., NOVICK, W. J. AND PETERSON, P. K.: Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone. J. Infect. Dis. 166: 847-853, 1992a.
9. CHAO, C. C., Hu, S., MOLITOR, T. W., SHASKAN, E. G. AND PETERSON, P. K.: Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149: 2736-2741, 1992b.
10. CHAO, C. C., GEKKER, G., Hu, S., SHENG, W. S., PORTOGHESE, P. S. AND PETERSON, P. K.: Upregulation of HIV-1 expression in cocultures of chronically infected promonocytes and human brain cells by dynorphin. Biochem, Pharmacol. 50: 715-722, 1995a.
11. CHAO, C. C., GEKKER, G., SHENG, W. S., Hu, S., PORTOGHESE, P. S. AND PETERSON. P. K.: Endogenous opioid peptides suppress cytokine-mediated upregulation of HIV-1 expression in the chronically infected promonocyte clone U1. In Brain Immune Axis and Substance Abuse, ed. by B. Sharp, T. Eisenstein, J. Madden and H. Friedman, pp. 65-72, Plennum Press, London, 1995b.
12. CHUNG, I. Y. AND BENVENSTEIN, E. N.: Tumor necrosis factor production by adtrocytes. J. Immunol. 144: 2999-3007, 1990.
13. 5]-enkephalin on interleukin-1β secretion from microglia in mixed brain cell cultures. J. Neuroimmunol. 62: 9-17, 1995.
14. DAWSON, V. L., DAWSON, T. M., UHL, G. R. AND SNYDER, S. H.: Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc. Natl. Acad. Sci. U.S.A. 90: 3256-3259, 1993.
15. DAWSON, V. L., BRAHMBHATT, H. P., MONO, J. A. AND DAWSON. T. M.: Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. Neuropharmacology 33: 1425-1430, 1994.
16. EFANOV, A. M., KOSHKIN, A. A., SAZANOV, L. A., BORODULINA, O. I., VARFOLOMEEV, S. D. AND ZAITSEV, S. V.: Inhibition of the respiratory burst in mouse macrophages by ultra-low doses of an opioid peptide is consistent with a possible adaptation mechanism. FEBS Lett. 335: 114-116, 1994.
17. FEINSTEIN, D. L., GALEA, E., CERMAK, J., CHUGH, P., LYANDVERT, L. AND REIS, D. J.: Nitric oxide synthase expression in glial cells: Suppression by tyrosine kinase inhibitors. J. Neurochem. 62: 811-814, 1994.
18. FOSTER, J. S. AND MOORE, R. N.: Dynorphin and related opioid peptides enhance tumoricidal activity mediated by murine peritoneal macrophages. J. Leuk. Biol. 42: 171-174, 1987.
19. GEHRMANN, J., MASTUMOTO, Y. AND KREUTZBERG, G. W.: Microglia: Intrinsic immuneffector cell of the brain, Brain Res. Rev. 20: 269-287, 1995.
20. GIULIAN, D., LI, J., Li, X., GEORGE, J. AND RUTECKI, P. A.: The impact of microglia-derived cytokines upon gliosis in the CNS. Dev. Neurosci. 16: 128-136, 1994.
21. HEIJNEN, C. J., KAVELAARS, A. AND BALLIEUX, R. E.: β-Endorphin: Cytokine and neuropeptide. Immunol. Rev. 119: 41-63, 1991.
22. HETIER, E., AYALA, J., BOUSSEAU, A., DENEFLE, P. AND PBOCHIANTZ, A.: Ameboid microglial cells and not astrocytes synthesize TNFα in Swiss mouse brain cell cultures. Eur. J. Neurosci. 2: 762-768, 1990.
23. HEWETT, S. J., CSERNANSKY, C. A. AND CHOI, D. W.: Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron 13: 487-494, 1994.
24. ICHINOSE, M., ASAI, M. AND SAWADA, M.: Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages. J. Neuroimmunol. 60: 37-43, 1995.
25. JOHNSON, H. M., SMITH, E. M., TORRES, B. A. AND BLOCK, J. E.: Regulation of the in vitro antibody response by neuroendocrine hormones. Proc. Natl. Acad. Sci. U. S. A. 79: 4171-4174, 1982.
26. KONG, L.-Y., McMILLIAN, M. K., MARONPOT, R. AND HONG, J.-S.: Protein tyrosine kinase inhibitors suppress the production of nitric oxide in mixed glia, microglia- enriched or astrocyte-enriched cultures. Brain Res. 729: 102-109, 1996.
27. KONG, L.-Y., WILSON, B. C., MCMILLIAN, M. K., BING, G., HUDSON, P. M. AND HONG, J.-S.: The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell. Immunol. 172: 77-83, 1996.
28. LIEBERMAN, A. P., PITHA, P. M., SHIN, H. S. AND SHIN, M. L.: Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl. Acad. Sci. U.S.A. 86: 6348-6352, 1989.
29. 3H]phorbol-12,13-dibutyrate binding by AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) in neonatal striatal cell cultures. Brain Res. 593: 307-310, 1992.
30. MCMILLIAN, M., KONG, L.-Y., MULLIS SAWIN, S., WILSON, B., DAS, K., HUDSON, P., HONG, J.-S. AND BING, G.: Selective killing of cholinergic neurons by microglial activation in basal forebrain mixed neuronal/glial cultures. Biochem. Biophys. Res. Commun. 215: 572-577, 1995.
31. MONCADA, S., PALMER, R. M. J. AND HIGGS, E. A.: Nitric oxide: Physiology, pathology, and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
32. PRETE, P., LEVIN, E. R. AND PEDRAM, A.: The in vitro effects of endogenous opiates on natural killer cells, antigen-specific cytolytic cell, and T-cell subsets. Exp. Neurol. 92: 340-359, 1986.
33. SACERDOTE, P., BIANCHI, M. AND MANFREDI, B.: Intracerebroventricular interleukin-1α increases immunocyte β-endorphin concentrations in the rat: Involvement of corticotropin-releasing hormone, catecholamines, and serotonin. Endocrinology 135: 1346-1352, 1994.
34. SCHOBITZ, B., KLOET, E. R. AND HOLSBOER, E.: Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog. Neurobiol. 44: 397-432, 1994.
35. SELMAJ, K. W. AND RAINE, C. S.: Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23: 339-346, 1988.
36. SHARP, B. M., KEANE, W. F., SUH, W. J., GEKKER, G., TSUKAYAMA, D. AND PETERSON, P. K.: Opioid peptides rapidly stimulate Superoxide production by human polymorphonuclear leukocytes and macrophages. Endocrinology 117: 793-795, 1985.
37. SIBINGA, N. E. AND GOLDSTEIN, A.: Opioid peptides and opioid receptors in cells of the immune system. Annu. Rev. Immunol. 6: 219-249, 1988.
38. SIMON, E. J.: Recent studies on opioid receptors: Heterogeneity and purification. Ann. N.Y. Acad. Sci. 463: 31-35, 1986.
39. STEFANO, G. B.: Role of opioid neuropeptides in immunoregulation. Prog. Neurobiol. 33: 149-159, 1989.
40. STUEHR, D. J. AND NATHAN, C. F.: Nitric oxide: A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169: 1543- 1555, 1989.
41. TOSK, J. M., GRIM, J. R., KINBACK, K. M., SALE, E. J., BOZZETTI, L. P. AND WILL, A. D.: Modulation of chemiluminescence in a murine macrophage cell line by neuroendocrine hormones. Int. J. Immunopharmacol. 15: 615-620, 1993.
42. WILLIAMSON, S. A., KNIGHT, R. A., LIGHTMAN, S. L. AND HOBBS, J. R.: Effects of beta endorphin on specific immune responses in man. Immunology 66: 47-51, 1988.
43. 2]methionine enkephalinamide. FEBS Lett. 291: 84-86, 1991.